Amoxicillin Sodium and Clavulanate Potassium for Injection 1.2g

• Customization: Available
• Package: 10vials/Box
• Composition: Amoxicillin Sodium and Clavulanate Potassium
• Model NO.: 1.2g
• Transport Package: Free
• Specification: 1.2g
• Trademark: Sinolead
• Origin: China

Product Description

Product	Dose	Package
Amoxicillin Sodium and Clavulanate Potassium For Injection	1.2g	10vials/box

• Amoxicillin Sodium and Clavulanate Potassium for Injection is a sterile powder containing amoxicillin sodium and clavulanate potassium, which is a beta-lactamase inhibitor. It is formulated for intravenous administration and provides rapid onset of therapeutic effects.

Indications:
 

Amoxicillin Sodium and Clavulanate Potassium for Injection is indicated for the treatment of various severe bacterial infections, including:

Lower respiratory tract infections: It is used for the treatment of pneumonia, bronchitis, and exacerbations of chronic obstructive pulmonary disease (COPD).

Intra-abdominal infections: It may be employed in the management of peritonitis, appendicitis, and cholecystitis.

Skin and soft tissue infections: It helps treat cellulitis, abscesses, and diabetic foot infections.

Urinary tract infections: It is indicated for the treatment of complicated urinary tract infections, including pyelonephritis.

 

 

Administration and Dosage:

Amoxicillin Sodium and Clavulanate Potassium for Injection is reconstituted with sterile water for injection to form a solution for intravenous infusion. The dosage and administration schedule depend on factors such as the type and severity of the infection, patient's weight, renal function, and treatment response. It is administered by a healthcare professional in a clinical setting, with close monitoring for adverse effects.

Precautions:

Healthcare providers should assess the patient's medical history, allergy status, and susceptibility of the infecting organism before initiating treatment with Amoxicillin Sodium and Clavulanate Potassium for Injection. Patients should be monitored closely for signs of adverse effects, with appropriate supportive care measures implemented as needed.